MiNA Therapeutics Denmark ApS — Credit Rating and Financial Key Figures

CVR number: 43329545
Frederikskaj 10 B, 2450 København SV

Income statement (kDKK)

2022
2023
Fiscal period length1212
Net sales
Gross profit-1 014.4511 343.38
Employee benefit expenses-4 728.81-4 460.88
Total depreciation-8.50-7.64
EBIT-5 751.766 874.86
Other financial income0.201.60
Other financial expenses-1.41-4.99
Pre-tax profit-5 752.976 871.47
Income taxes- 247.49
Net earnings-5 752.976 623.98

Assets (kDKK)

2022
2023
Intangible assets total
Machinery and equipment14.406.77
Tangible assets total14.406.77
Investments total8.168.16
Long term receivables total
Inventories total
Current amounts owed by group member comp.1 711.63
Prepayments and accrued income13.272.15
Current other receivables364.08412.03
Current deferred tax assets1.33
Short term receivables total377.352 127.14
Balance sheet total (assets)399.922 142.07

Equity and liabilities (kDKK)

2022
2023
Share capital40.0040.00
Retained earnings-5 752.97
Profit of the financial year-5 752.976 623.98
Shareholders equity total-5 712.97911.00
Non-current owed to group member5 405.91
Non-current liabilities total5 405.91
Current trade creditors66.5960.73
Short-term deferred tax liabilities248.82
Other non-interest bearing current liabilities608.23839.70
Accruals and deferred income32.1681.82
Current liabilities total706.981 231.06
Balance sheet total (liabilities)399.922 142.07
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.